Morgan Wealth Management Group | Financial service

Morgan Wealth Management Group

Phone: +61 1300 612 882

Add/Update information

Reviews

Tags

• Businesses
• Financial service
• Finance

28.01.2022 Happy customers lead to happy shareholders - https://www.morganwealth.com.au/?p=1081

23.01.2022 Pharmaceutical powerhouse CSL continues to shine Biotech company CSL this morning reported a strong profit growth of 29% for the year, beating its own management guidance provided in May. Revenue increased across the board, including new product launches and the plasma business. According to CEO Paul Perreault, the tightness in supply of our key raw material, plasma, has been a feature across the industry this year. The CSL Plasma team have opened 27 new collection centers i...n the US a growth rate unmatched in the industry. Management also provided guidance for fiscal 2019, anticipating 10-14% profit growth. CSL’s potential blockbuster medicine targeting recurrent heart attacks, CSL112, entered phase 3 trial during the year. If successful, according to Morningstar research it could see a commercial launch by 2023 and could reach USD 10 billion in revenues by 2029. CSL remains one of Australia’s great pharmaceutical success stories, driven by well-executed international expansion, and high investment in research and development. It is one of Morgan Wealth’s core holdings and has produced a return of 57% for the 12 months ended 31 July 2018. See more

18.01.2022 We will be watching auction clearance rates very closely for definitive evidence that the domestic property market is tanking.

15.01.2022 Companies that wish to succeed in China must grasp an in-depth understanding of the political, business and sociological environment. There are many different factors at play when considering international expansion, and sometimes companies can rush decisions without the due consideration they deserve.

07.01.2022 ResMed shareholders also sleep well at night Sleep device maker ResMed has just recently reported a 13% increase in revenue for the year ended 30 June 2018 together with a 27% increase in operating income. Chief Executive, Mick Farrell, was reported as saying that we closed out the year with strong performance across all aspects of our business, from solid top-line revenue growth, driven by geographically balanced results across our entire portfolio of offerings. The company is well positioned for fiscal year 2019. Resmed is one of Morgan Wealth’s core shareholdings and has produced a return of 47% for the 12 months ended 31 July 2018.

02.01.2022 Shares of Australian based software developer Altium Ltd soar 32% - https://www.morganwealth.com.au/?p=1065

02.12.2021 "The large banks and AMP will be required to fund the establishment of a new independent body to oversee the professional standing of the financial services industry, yet, the new professional standards regime for the industry will not start until 2019 and will take until 2024 to be fully operational."

20.11.2021 Contracts have governed the workings of the economy since ancient times. As technology improves and organizations become more complex, the theory and practice of contract design will only increase in importance.

03.11.2021 We are on the cusp of a revolutionary global paradigm shift towards renewable energy, and Malcolm Turnbull seems to be comfortable keeping Australia from realising it's true potential as a global leader in the evolution of renewable technologies.

31.10.2021 Subscribe to our monthly newsletter for our independently researched investor news and consistently updated top stock recommendations.

16.10.2021 There is room for a deeper analysis to be had into the numerous challenges associated with using the tax transfer system to support R&D, but this stands as an adequate conversation opener.

11.10.2021 Would come to work just for the views

09.10.2021 At Morgan Wealth, we think Orocobre is a very promising Lithium producer and have recently included it in our Client Model Portfolios. Orocobre is one of the few mining companies actually in commercial production. With the soaring demand for lithium batteries for EV and electricity grid storage, we think that the company will continue to excel over the foreseeable future.